7FNY
 
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P07F10 from the F2X-Universal Library | | Descriptor: | 4-[(acetyloxy)methyl]benzoic acid, A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.71 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FLV
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P05G05 from the F2X-Universal Library | | Descriptor: | (1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethane-1,2-diamine, A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.51 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FM3
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P05H09 from the F2X-Universal Library | | Descriptor: | A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8, methyl 4,5,6,7-tetrahydro-2H-indazole-3-carboxylate | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.65 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FMA
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P06B04 from the F2X-Universal Library | | Descriptor: | A1 cistron-splicing factor AAR2, N-[2-(aminomethyl)phenyl]methanesulfonamide, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.41 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FOK
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P08B09 from the F2X-Universal Library | | Descriptor: | A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8, methyl N-methyl-N-[(2E)-3-(thiophen-3-yl)prop-2-enoyl]glycinate | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.72 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FOT
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P08D03 from the F2X-Universal Library | | Descriptor: | (3E)-N-benzyl-3-(hydroxyamino)-3-iminopropanamide, A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.56 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FP1
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P08F04 from the F2X-Universal Library | | Descriptor: | A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8, methyl N-(propan-2-yl)-N-(thiophene-3-carbonyl)glycinate | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.43 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FPI
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P10C11 from the F2X-Universal Library | | Descriptor: | A1 cistron-splicing factor AAR2, N,N'-dicyclopropyl-N-(prop-2-en-1-yl)urea, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.63 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7FPJ
 | | PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment P10D05 from the F2X-Universal Library | | Descriptor: | 1-(1-benzyl-1H-imidazol-2-yl)methanamine, A1 cistron-splicing factor AAR2, Pre-mRNA-splicing factor 8 | | Authors: | Barthel, T, Wollenhaupt, J, Lima, G.M.A, Wahl, M.C, Weiss, M.S. | | Deposit date: | 2022-08-26 | | Release date: | 2022-11-02 | | Last modified: | 2024-05-22 | | Method: | X-RAY DIFFRACTION (1.59 Å) | | Cite: | Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.
J.Med.Chem., 65, 2022
|
|
7HUD
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B08 from the F2X-Entry Screen in monoclinic space group | | Descriptor: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-01-07 | | Release date: | 2025-01-15 | | Method: | X-RAY DIFFRACTION (1.61 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7HUC
 | |
7HUE
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment D08 from the F2X-Entry Screen in monoclinic space group | | Descriptor: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, N-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N,N',N'-trimethylurea | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-01-07 | | Release date: | 2025-01-15 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1D
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment F04 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I14
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B08 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1H
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment G10 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 1-phenyl-1H-tetrazole, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.98 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1J
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment H11 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.85 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I16
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment C07 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3,4-dihydro-1~{H}-quinolin-2-one, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (2.13 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I18
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment D04 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1A
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment D11 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3-(1,3-thiazol-2-yl)propanoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.73 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I19
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment D08 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.93 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1G
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment G09 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | (2R)-2-(acetylamino)-4-phenylbutanoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.83 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I17
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment C10 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 1,3-benzodioxole-5-carbothioamide, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.69 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I15
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment C02 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 2,4,5-tris(fluoranyl)-3-methoxy-benzoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I13
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B05 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 2-acetylbenzoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ... | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
7I1C
 | | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment E11 from the F2X-Entry Screen in orthorhombic space group | | Descriptor: | 3C-like proteinase nsp5, CHLORIDE ION, [2-(morpholin-4-yl)-1,3-thiazol-5-yl]methanol | | Authors: | Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S. | | Deposit date: | 2025-02-03 | | Release date: | 2025-05-21 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening
To be published
|
|
